Patents by Inventor Helene SAVIGNAC

Helene SAVIGNAC has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11779613
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing neurodegenerative disorders.
    Type: Grant
    Filed: April 2, 2021
    Date of Patent: October 10, 2023
    Assignee: CJ BIOSCIENCE, INC.
    Inventors: Imke Elisabeth Mulder, Samantha Yuille, Anna Ettorre, Suaad Ahmed, Parthena Fotiadou, Joseph Roby Iringan Urcia, Helene Savignac
  • Patent number: 11660319
    Abstract: The invention provides compositions comprising commensal bacterial strains and organic acids and the uses thereof in the treatment of diseases.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 30, 2023
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Anna Ettorre, Suaad Ahmed, Parthena Fotiadou, Samantha Yuille, Joseph Roby Iringan Urcia, Helene Savignac
  • Publication number: 20230134714
    Abstract: The invention provides compositions comprising bacterial strains for use in therapy.
    Type: Application
    Filed: August 17, 2022
    Publication date: May 4, 2023
    Inventors: Samantha YUILLE, Nicole REICHARDT, Sarah REID, Suaad AHMED, Helene SAVIGNAC, Imke Elisabeth MULDER, Anna ETTORRE
  • Publication number: 20230135434
    Abstract: The invention provides compositions comprising a bacterial strain of the genus Fusicatenibacter and their use in medicine.
    Type: Application
    Filed: May 19, 2022
    Publication date: May 4, 2023
    Inventors: Imke Elisabeth MULDER, Nicole REICHARDT, Helene SAVIGNAC, Sasha CHETAL, Ted DINAN, John CRYAN
  • Patent number: 11504405
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing lung injury or lung disease.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: November 22, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Mulder, Alexander Stevenson, Helene Savignac
  • Publication number: 20220265733
    Abstract: The invention provides pharmaceutical compositions comprising bacteria and the use of such compositions in the treatment of disease.
    Type: Application
    Filed: December 17, 2021
    Publication date: August 25, 2022
    Inventors: Imke Elisabeth MULDER, Nicole REICHARDT, Helene SAVIGNAC, Sasha CHETAL, Ted DINAN, John CRYAN, Samantha YUILLE
  • Patent number: 11382936
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing autoimmune and inflammatory disorders of the central nervous system.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: July 12, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: Helene Savignac, Imke Elisabeth Mulder, Alexander James Stevenson
  • Patent number: 11376284
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing central nervous system disorders and conditions.
    Type: Grant
    Filed: November 22, 2019
    Date of Patent: July 5, 2022
    Assignee: 4D Pharma Research Limited
    Inventors: Helene Savignac, Imke Elisabeth Mulder, Alexander James Stevenson, Ted Dinan, John Cryan
  • Publication number: 20220184145
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing central nervous system disorders and conditions.
    Type: Application
    Filed: November 19, 2021
    Publication date: June 16, 2022
    Inventors: Helene SAVIGNAC, Imke Elisabeth MULDER, Alexander James STEVENSON, Ted DINAN, John CRYAN
  • Publication number: 20220096565
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing a neurodegenerative disorder.
    Type: Application
    Filed: August 19, 2021
    Publication date: March 31, 2022
    Inventors: Imke Elisabeth MULDER, Anna ETTORRE, Suaad AHMED, Parthena FOTIADOU, Samantha YUILLE, Helene SAVIGNAC
  • Publication number: 20220031772
    Abstract: The invention provides compositions comprising a bacterial strain of the species Blautia producta or Blautia coccoides, for use in therapy.
    Type: Application
    Filed: April 15, 2021
    Publication date: February 3, 2022
    Inventors: Samantha YUILLE, Helene SAVIGNAC, Sarah REID, Imke Elisabeth MULDER, Nicole REICHARDT, Emma RAFTIS
  • Publication number: 20220016184
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing brain injury.
    Type: Application
    Filed: July 22, 2021
    Publication date: January 20, 2022
    Inventors: Helene SAVIGNAC, Imke Elisabeth MULDER, Alexander James STEVENSON
  • Publication number: 20210338746
    Abstract: The invention provides compositions comprising a viable bacterial strain of the genus Pediococcus, for use in treating or preventing inflammatory or autoimmune disease.
    Type: Application
    Filed: March 18, 2021
    Publication date: November 4, 2021
    Inventors: Suaad AHMED, Imke Elisabeth MULDER, Emma RAFTIS, Nicole REICHARDT, Sarah REID, Helene SAVIGNAC, Joseph Roby Iringan URCIA, Samantha YUILLE
  • Publication number: 20210315943
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing neurodegenerative disorders.
    Type: Application
    Filed: April 2, 2021
    Publication date: October 14, 2021
    Inventors: Imke Elisabeth MULDER, Samantha YUILLE, Anna ETTORRE, Suaad AHMED, Parthena FOTIADOU, Joseph Roby Iringan URCIA, Helene SAVIGNAC
  • Patent number: 11123378
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing brain injury.
    Type: Grant
    Filed: November 21, 2019
    Date of Patent: September 21, 2021
    Assignee: 4D Pharma Research Limited
    Inventors: Helene Savignac, Imke Elisabeth Mulder, Alexander James Stevenson
  • Patent number: 11123379
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing a neurodegenerative disorder.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: September 21, 2021
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Anna Ettorre, Suaad Ahmed, Parthena Fotiadou, Samantha Yuille, Helene Savignac
  • Publication number: 20210275606
    Abstract: This invention is in the field of compositions comprising bacterial strains isolated from the mammalian digestive tract and the use of such compositions in the treatment of disease.
    Type: Application
    Filed: December 14, 2020
    Publication date: September 9, 2021
    Inventors: Sam YUILLE, Helene SAVIGNAC, Suaad AHMED, Sarah REID, Imke MULDER, Nicole REICHARDT, Emma RAFTIS, Anna ETTORRE, Grainne LENNON
  • Publication number: 20210275607
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing lung injury or lung disease.
    Type: Application
    Filed: January 15, 2021
    Publication date: September 9, 2021
    Inventors: Imke MULDER, Alexander STEVENSON, Helene SAVIGNAC
  • Publication number: 20210196765
    Abstract: Provided are compositions comprising a bacterial strain of the genus Blautia, for use in a method of increasing the microbiota diversity and/or stability of the microbiota of a subject.
    Type: Application
    Filed: September 30, 2020
    Publication date: July 1, 2021
    Inventors: Ian JEFFERY, Fergus SHANAHAN, Paul O'TOOLE, Alex STEVENSON, Imke MULDER, Helene SAVIGNAC
  • Patent number: 11007233
    Abstract: The invention provides compositions comprising bacterial strains for treating and preventing neurodegenerative disorders.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 18, 2021
    Assignee: 4D Pharma Research Limited
    Inventors: Imke Elisabeth Mulder, Samantha Yuille, Anna Ettorre, Suaad Ahmed, Parthena Fotiadou, Joseph Roby Iringan Urcia, Helene Savignac